Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
Study of Longitudinal Plasma PD-L1 Testing With Immunotherapy in Lung Cancer
ClinicalTrials.gov study NCT06849518. IPD Sharing: NO. Countries: 1. Publications: 0.
Zimberelimab (AB122) With TIGIT Inhibitor Domvanalimab (AB154) in PD-1 Relapsed/Refractory Melanoma
ClinicalTrials.gov study NCT05130177. IPD Sharing: NO. Countries: 1. Publications: 0.
PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients
ClinicalTrials.gov study NCT06359275. IPD Sharing: NO. Countries: 1. Publications: 0.
Chinese PD Registry
ClinicalTrials.gov study NCT03887663. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT03930498. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
ClinicalTrials.gov study NCT07209189. IPD Sharing: NO. Countries: 0. Publications: 0.
A Feasibility Study of Peritoneal Dialysis With CLS PD, Which Removes Toxins and Maintains a Stable Ultrafiltration by Continuously Regenerating a Recirculating Intraperitoneal Fluid, in Patients With
ClinicalTrials.gov study NCT03190018. IPD Sharing: NO. Countries: 1. Publications: 0.
Predicting Clinical Efficacy of Immunotherapy Using Pre-treatment andContinuousMonitoring of PD-L1 TPS/CPS on CTCs, and Immunity Exhaustion Scores
ClinicalTrials.gov study NCT07396259. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular
ClinicalTrials.gov study NCT06961370. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Unresectable Locally Advanced or Recurrent Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT06471205. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CGM in Icodextrin PD
ClinicalTrials.gov study NCT06838819. IPD Sharing: NO. Countries: 1. Publications: 0.
First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic Radiotherapy
ClinicalTrials.gov study NCT06586697. IPD Sharing: NO. Countries: 1. Publications: 0.
Anti-PD-1 Alone or Combined With Autologous Cell Therapy in Advanced NSCLC
ClinicalTrials.gov study NCT03360630. IPD Sharing: NO. Countries: 1. Publications: 0.
SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer
ClinicalTrials.gov study NCT07297030. IPD Sharing: NO. Countries: 1. Publications: 0.
PD-HF: A Trial of Peritoneal Dialysis in Patients With Severe Heart Failure and Chronic Kidney Disease
ClinicalTrials.gov study NCT02708407. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Consortium On Risk for Early-onset Parkinson's Disease (CORE PD)
ClinicalTrials.gov study NCT00104585. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy Volunteers
ClinicalTrials.gov study NCT00745186. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Safety and Efficacy of PD-1 Monoantrapical Chemotherapy in the Treatment of Local Advanced Stomach Cancer
ClinicalTrials.gov study NCT05000554. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks
ClinicalTrials.gov study NCT01658501. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined With Centipeda Minima (CM) in Lung Cancer
ClinicalTrials.gov study NCT05735028. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.